Randall R. Miller

1.3k citations

27 papers · 905 indexed · h-index 18

Molecular Biology
Pharmacology top 2%
Oncology
Organic Chemistry
Endocrinology, Diabetes and Metabolism top 10%

Co-authors: Ralph A. Stearns Byron H. Arison Gary H. Rasmusson Charles J. Waechter Dennis Dean Thomas A. Baillie Ali Shafiee Haideh Motamedi
Topics: Pharmacogenetics and Drug Metabolism (7 papers)Adipose Tissue and Metabolism (4 papers)Pharmacological Effects and Assays (4 papers)
Cited by: Pharmacology Endocrinology, Diabetes and Metabolism Pharmaceutical Science
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Bacteriology
Partner nations: United States Türkiye Canada

In The Last Decade

Randall R. Miller

27 papers receiving 849 citations

Peers

Countries citing papers authored by Randall R. Miller

Since Specialization

Citations

This map shows the geographic impact of Randall R. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall R. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall R. Miller more than expected).

Fields of papers citing papers by Randall R. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall R. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall R. Miller. The network helps show where Randall R. Miller may publish in the future.

Co-authorship network of co-authors of Randall R. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Randall R. Miller. A scholar is included among the top collaborators of Randall R. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall R. Miller. Randall R. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PvNAC1 and PvNAC2 Are Associated with Leaf Senescence and Nitrogen Use Efficiency in Switchgrass 2014 ·BioEnergy Research ·Jiading Yang,(unknown),Ivone Torres‐Jerez,Randall R. Miller,Mingyi Wang,Chunxiang Fu,Zeng‐Yu Wang,Yuhong Tang,Michael K. Udvardi	17
2	2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Brenda L. Palucki,(unknown),Ravi P. Nargund,Rui Tang,Tanya MacNeil,David H. Weinberg,Aurawan Vongs,Charles Rosenblum,George A. Doss,Randall R. Miller,Ralph A. Stearns,(unknown),Constantin Tamvakopoulos,Lex H.T. Van der Ploeg,Arthur A. Patchett	18
3	A semi-automated method for measuring the potential for protein covalent binding in drug discovery 2005 ·Journal of Pharmacological and Toxicological Methods ·Stephen H. Day,(unknown),Ronald E. White,Timothy Schulz-Utermoehl,Randall R. Miller,Maria Beconi	50
4	Metabolic Activation of a 1,3-Disubstituted Piperazine Derivative: Evidence for a Novel Ring Contraction to an Imidazoline 2005 ·Chemical Research in Toxicology ·George A. Doss,Randall R. Miller,Zhoupeng Zhang,Yohannes Teffera,Ravi P. Nargund,Brenda L. Palucki,(unknown),Yui S. Tang,David C. Evans,Thomas A. Baillie,Ralph A. Stearns	27
5	IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT 2004 ·Drug Metabolism and Disposition ·Randall R. Miller,George A. Doss,Ralph A. Stearns	14
6	Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate 2002 ·Drug Metabolism and Disposition ·Wei Tang,Ralph A. Stearns,Randall R. Miller,Jason S. Ngui,Robert J. Mathvink,Ann E. Weber,Gloria Y. Kwei,John R. Strauss,Carol Keohane,George A. Doss,Shuet-Hing Lee Chiu,Thomas A. Baillie	8
7	Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist 2000 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Tesfaye Biftu,Mari R. Candelore,Margaret A. Cascieri,Lawrence F. Colwell,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Randall R. Miller,Ralph A. Stearns,Catherine D. Strader,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	15
8	Discovery of a Potent, Orally Bioavailable β₃ Adrenergic Receptor Agonist, (R)-N-[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide 2000 ·Journal of Medicinal Chemistry ·Robert J. Mathvink,(unknown),(unknown),Mari R. Candelore,Margaret A. Cascieri,Lawrence F. Colwell,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Randall R. Miller,Ralph A. Stearns,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	51
9	Cytochrome P450 3A4-Mediated Interaction of Diclofenac and Quinidine 2000 ·Drug Metabolism and Disposition ·Jason S. Ngui,Wei Tang,Ralph A. Stearns,Magang Shou,Randall R. Miller,Yong Zhang,Jiunn H. Lin,Thomas A. Baillie	58
10	L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability 1999 ·Bioorganic & Medicinal Chemistry Letters ·Thomas L. Shih,Mari R. Candelore,Margaret A. Cascieri,Shuet‐Hing Lee Chiu,Lawrence F. Colwell,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Randall R. Miller,Ralph A. Stearns,Catherine D. Strader,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	41
11	Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides 1999 ·Bioorganic & Medicinal Chemistry Letters ·Emma R. Parmee,Elizabeth M. Naylor,(unknown),Vincent J. Colandrea,Hyun Ok,Mari R. Candelore,Margaret A. Cascieri,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Randall R. Miller,Ralph A. Stearns,Catherine D. Strader,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	25
12	Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism 1999 ·Journal of Pharmacology and Experimental Therapeutics ·Wei Tang,Ralph A. Stearns,Gloria Y. Kwei,Susan A. Iliff,Randall R. Miller,(unknown),Nathan X. Yu,Dennis Dean,Sanjeev Kumar,Magang Shou,Jiunn H. Lin,Thomas A. Baillie	61
13	Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. 1997 ·PubMed ·Kathryn Thompson,S H Vincent,Randall R. Miller,(unknown),Raúl Álvaro,M A Wallace,William P. Feeney,(unknown)	37
14	Chemical and Biological Characterization of Two FK506 Analogs Produced by Targeted Gene Disruption in Streptomyces sp. MA6548. 1997 ·The Journal of Antibiotics ·Ali Shafiee,Haideh Motamedi,Francis J. Dumont,Byron H. Arison,Randall R. Miller	14
15	Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. 1996 ·Drug Metabolism and Disposition ·Kwan Leung,Dosinda Cohn,Randall R. Miller,George A. Doss,Ralph A. Stearns,Richard E. Simpson,William P. Feeney,S H Chiu	8
16	Flanking and Intragenic Sequences Regulating the Expression of the Rabbit α-Globin Gene 1995 ·Journal of Biological Chemistry ·(unknown),Susan E. Yost,Brian M. Shewchuk,(unknown),Randall R. Miller,Ross C. Hardison	16
17	Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. 1995 ·Drug Metabolism and Disposition ·Su-Er W. Huskey,Dennis Dean,Randall R. Miller,Gary H. Rasmusson,(unknown)	54
18	Structural features and some binding properties of proteoheparan sulfate enzymatically labeled by calf brain microsomes 1984 ·Archives of Biochemistry and Biophysics ·Randall R. Miller,Charles J. Waechter	4
19	Comparison of the chemical, physical, and survival properties of normal and Z-variant alpha-1-antitrypsins. 1976 ·Journal of Biological Chemistry ·Randall R. Miller,Mark S. Kuhlenschmidt,C J Coffee,Ingrid Kuo,Robert H. Glew	43
20	A NEW BIOLOGICALLY POTENT STEROID: 1-DEHYDRO-9α-FLUOROHYDROCORTISONE ACETATE 1955 ·Journal of the American Chemical Society ·Ralph Hirschmann,Randall R. Miller,Roger E. Beyler,Lewis H. Sarett,Max Tishler	20

About Randall R. Miller

Randall R. Miller is a scholar working on Pharmacology, Animal Science and Zoology and Pharmaceutical Science, having authored 27 papers that have together received 905 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Adipose Tissue and Metabolism (4 papers) and Pharmacological Effects and Assays (4 papers). The work is most often cited by research in Pharmacology (249 citations), Endocrinology, Diabetes and Metabolism (114 citations) and Pharmaceutical Science (40 citations). Randall R. Miller has collaborated with scholars based in United States, Türkiye and Canada. Frequent co-authors include Ralph A. Stearns, Byron H. Arison, Gary H. Rasmusson, Charles J. Waechter, Dennis Dean, Thomas A. Baillie, Ali Shafiee, Haideh Motamedi, William P. Feeney and Wei Tang. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact